Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Mattarollo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer Research|October 26, 2013
An intact immune system is required for the anticancer activities of histone deacetylase inhibitorsAlison C West, Stephen R Mattarollo, Jake Shortt, et al.
Plos One|March 8, 2013
Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytesAllison Choyce, Michelle Yong, Sharmal Narayan, et al.
International Journal of Cancer|March 1, 2008
V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumabHirotake Tokuyama, Tomomi Hagi, Stephen R Mattarollo, et al.
Oncoimmunology|October 6, 2018
Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemiaDaniel Kerage, Megan S F Soon, Brianna L Doff, et al.
Oncoimmunology|January 9, 2018
B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activitySara J McKee, Zewen K Tuong, Takumi Kobayashi, et al.
Blood|August 31, 2012
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphomaStephen R Mattarollo, Alison C West, Kim Steegh, et al.
Blood|August 21, 2020
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environmentTakumi Kobayashi, Pui Yeng Lam, Hui Jiang, et al.
Cancer Research|December 5, 2013
CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapyYuting Ma, Stephen R Mattarollo, Sandy Adjemian, et al.
Oncoimmunology|June 17, 2022
Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effectKef K Prasit, Laura Ferrer-Font, Olivia K Burn, et al.
The Journal of Experimental Medicine|March 9, 2011
Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapyYuting Ma, Laetitia Aymeric, Clara Locher, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Research|October 26, 2013
An intact immune system is required for the anticancer activities of histone deacetylase inhibitorsAlison C West, Stephen R Mattarollo, Jake Shortt, et al.
Plos One|March 8, 2013
Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytesAllison Choyce, Michelle Yong, Sharmal Narayan, et al.
International Journal of Cancer|March 1, 2008
V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumabHirotake Tokuyama, Tomomi Hagi, Stephen R Mattarollo, et al.
Oncoimmunology|October 6, 2018
Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemiaDaniel Kerage, Megan S F Soon, Brianna L Doff, et al.
Oncoimmunology|January 9, 2018
B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activitySara J McKee, Zewen K Tuong, Takumi Kobayashi, et al.
Blood|August 31, 2012
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphomaStephen R Mattarollo, Alison C West, Kim Steegh, et al.
Blood|August 21, 2020
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environmentTakumi Kobayashi, Pui Yeng Lam, Hui Jiang, et al.
Cancer Research|December 5, 2013
CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapyYuting Ma, Stephen R Mattarollo, Sandy Adjemian, et al.
Oncoimmunology|June 17, 2022
Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effectKef K Prasit, Laura Ferrer-Font, Olivia K Burn, et al.
The Journal of Experimental Medicine|March 9, 2011
Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapyYuting Ma, Laetitia Aymeric, Clara Locher, et al.
Pageof 5